<DOC>
	<DOCNO>NCT02403687</DOCNO>
	<brief_summary>A 24-week observational prospective study efficacy topical non-steroidal anti-inflammatory drug relief pain .</brief_summary>
	<brief_title>Prospective Analgesic Compound Efficacy ( PACE ) Study</brief_title>
	<detailed_description>Objectives The primary objective change pain level measure 10-point visual analog scale ( VAS ) . Secondary objective change concomitant pain medication use , quality life , patient satisfaction pain management . Design Outcomes The study conduct 1 family practice medical clinic Houston , TX . Patients prescribed pain cream compound base symptom medical history . Periodic survey administer concomitant medication record ascertain current pain level , quality life , satisfaction current pain level . Blood test perform monitor liver kidney function . Interventions Duration Non-steroidal anti-inflammatory steroid ( NSAID ) topical cream prescribe patient present pain . For patient localized pain , also prescribe transdermal analgesic patch wear site pain . Subjects follow 24-weeks survey administer baseline , 1 , 2 , 4 , 8 , 12 , 16 , 20 , 24-weeks baseline blood test perform 12 24-weeks . If patient find satisfactory pain relief experience undesirable side effect cream give prescription oral NSAID anytime 24-week observation . Sample Size Population 500 patient enrol study March 1 , 2015 March 1 , 2017 . Subjects screen patient population 1960 Family Practice , 837 Cupress Creek Parkway , Suite 105 , Houston Texas . Subjects present primary complaint pain . Subjects stratify follow medical indication ; Arthritis Muscle Spasms Tendonitis Idiopathic Gout Synovitis Radiculopathy Migraine</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Synovitis</mesh_term>
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Cyclobenzaprine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<mesh_term>Tizanidine</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>4.1.1 Primary complaint clinical finding arthritis , tendonitis , gout , synovitis , radiculopathy , muscle spasm , migraine , and/or idiopathic pain . 4.1.2 No new pain medication kind last 4 week . 4.1.3 Between age 1885yrs . 4.2.1 Current history disease disorder liver , kidney , gastrointestinal system , cardiovascular system . 4.2.2 Blood test indicate kidney , liver , cardiovascular function outside normal clinically accept range . Blood test must perform last 7 day . 4.2.3 Broken inflame skin , burn , open wound , atopic dermatitis eczema area pain compound cream transdermal patch would apply . 4.2.4 Women pregnant , nursing , plan become pregnant next 52weeks . 4.2.5 Allergy/sensitivity study drug formulation . 4.2.6 Active drug alcohol use dependence , opinion site investigator , would interfere adherence study requirement . 4.2.7 Serious illness ( require systemic treatment and/or hospitalization ) subject either complete therapy clinically stable therapy , opinion site investigator , least 14 day prior study entry . 4.2.8 Inability unwillingness subject give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>